Assessment of left ventricular dyssynchrony by speckle tracking echocardiography in patients with Steinert's disease

ElsevierVolume 15, Issue 3, June 2023, Pages 261-262Archives of Cardiovascular Diseases SupplementsAuthor links open overlay panel, , , , , Introduction

Conduction system abnormalities and myocardial dysfunction are observed in patients with myotonic dystrophy type 1 (DM1) and may represent the initial manifestations of the disease.

Some studies have shown improvements of outcomes with use of early cardiac resynchronization therapy (CRT) in DM1 patients. Two-dimensional speckle tracking echocardiography (2D-STE) has recently emerged as a non-invasive biomarker for early detection of dyssynchrony. The aim of this study is to assess a left ventricle (LV) dyssynchrony using 2D-STE analysis in this population.

Method

This is a prospective study, conducted from March 2020 to October 2022 which included DM1 with normal LV ejection fraction (LVEF) and control patients with comprehensive resting echocardiography. Three measures were performed to assess LV mechanical dyssynchrony: opposing-wall delays (longitudinal and radial analyses), modified Yu index, and time to-peak delays of each segment.

Results

Mean age was 23 ± 7 years. All three mechanical dyssynchrony criteria were significantly higher in the DM1 group than in healthy subjects: opposing-wall delays in basal inferoseptal to basal anterolateral segments (61.4 ± 45.3 msec vs. 18.3 ± 50.4 msec, P < 0.001, respectively) and in mid inferoseptal to mid anterolateral segments (58.6 ± 35.3 msec vs. 42.4 ± 36.4 msec, P < 0.05, respectively) (Fig. 1), modified Yu index (33.3 ± 10.1 msec vs. 28.5 ± 8.1 msec, P < 0.05, respectively), and most of time-to-peak values, especially in basal and mid anterolateral segments.

Conclusion

The existence of an early LV mechanical dyssynchrony using 2D-STE analysis in DM1 patients before the onset of cardiomyopathy represents a perspective for early prediction of sudden heart death. However, are ICDs really beneficial in terms of improving overall survival, in patients with conduction system disease often presenting more severe forms of myotonic dystrophy itself. Mean corrected time-to-peak delays.

Section snippetsDisclosure of interest

The authors have not supplied their declaration of competing interest.

View full text

Copyright © 2023 Published by Elsevier Masson SAS

留言 (0)

沒有登入
gif